Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 4Phase NA 2Phase 4 2Phase 1 2

Status

Completed 4Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 3Myeloid 1

Conditions

Venous Thromboembolism 3Neoplasms 2Thrombosis 1Thrombocythemia, Essential 1Pulmonary Embolism 1Primary Myelofibrosis 1Polycythemia Vera 1Myeloproliferative Disorders 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × apixaban × Clear all
NCT04243122 2024-05-29

AIRPORT-MPN

Ottawa Hospital Research Institute

Phase 2 Completed
44 enrolled
Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

University of Colorado, Denver

Phase 2 Completed
400 enrolled 16 charts
Classical hematology

Venous Thromboembolism

NCT02048865 2018-11-20

AVERT

Ottawa Hospital Research Institute

Phase 2 Completed
575 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT00320255 2016-08-16

A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer

Bristol-Myers Squibb

Phase 2 Completed
130 enrolled 22 charts

Neoplasms, Pulmonary Embolism, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡